TRALOKINUMAB Pharmacologic Class Indexing
- Class set ID
- 2eb3876e-214e-418f-a7d5-e114160d3efa
- Version
- 1
- Effective date
- 20220322
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use ADBRY safely and effectively. See full prescribing information for ADBRY. ADBRY ® (tralokinumab-ldrm) injection, for subcutaneous use Initial U.S. Approval: 2021 | LEO Pharma Inc. | Catalent Indiana, LLC. | Astra Zeneca Pharmaceuticals LP | LEO Pharma A/S | 20251217 | 15 |